399 related articles for article (PubMed ID: 9398013)
1. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia.
Carman WF; Van Deursen FJ; Mimms LT; Hardie D; Coppola R; Decker R; Sanders R
Hepatology; 1997 Dec; 26(6):1658-66. PubMed ID: 9398013
[TBL] [Abstract][Full Text] [Related]
2. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
3. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
Mphahlele MJ; Lukhwareni A; Burnett RJ; Moropeng LM; Ngobeni JM
J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918
[TBL] [Abstract][Full Text] [Related]
4. Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers.
Roque-Afonso AM; Férey MP; Ly TD; Graube A; Costa-Faria L; Samuel D; Dussaix E
Antivir Ther; 2007; 12(8):1255-63. PubMed ID: 18240865
[TBL] [Abstract][Full Text] [Related]
5. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
[TBL] [Abstract][Full Text] [Related]
6. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.
Lukhwareni A; Burnett RJ; Selabe SG; Mzileni MO; Mphahlele MJ
J Med Virol; 2009 Mar; 81(3):406-12. PubMed ID: 19152393
[TBL] [Abstract][Full Text] [Related]
7. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH
J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793
[TBL] [Abstract][Full Text] [Related]
8. Detection of hepatitis B virus DNA in hepatitis B surface antigen-negative serum by polymerase chain reaction: evaluation of different primer pairs and conditions.
Gomes SA; Yoshida CF; Niel C
Acta Virol; 1996 Jun; 40(3):133-8. PubMed ID: 8891092
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
[TBL] [Abstract][Full Text] [Related]
10. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay.
Chevrier MC; St-Louis M; Perreault J; Caron B; Castilloux C; Laroche J; Delage G
Transfusion; 2007 Oct; 47(10):1794-802. PubMed ID: 17880603
[TBL] [Abstract][Full Text] [Related]
11. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan.
Mu SC; Lin YM; Jow GM; Chen BF
J Hepatol; 2009 Feb; 50(2):264-72. PubMed ID: 19070923
[TBL] [Abstract][Full Text] [Related]
12. Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population.
Roman S; Tanaka Y; Khan A; Kurbanov F; Kato H; Mizokami M; Panduro A
J Med Virol; 2010 Sep; 82(9):1527-36. PubMed ID: 20648606
[TBL] [Abstract][Full Text] [Related]
13. Reduced antigenicity of naturally occurring hepatitis B surface antigen variants with substitutions at the amino acid residue 126.
Qiu S; Zhang J; Tian Y; Yang Y; Huang H; Yang D; Lu M; Xu Y
Intervirology; 2008; 51(6):400-6. PubMed ID: 19258718
[TBL] [Abstract][Full Text] [Related]
14. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
Hsia CC; Scudamore CH; Di Bisceglie AM; Tabor E
J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.
Bouchardeau F; Girault A; Razer A; Servant-Delmas A; Mercier M; Laperche S
Transfusion; 2006 Dec; 46(12):2047-52. PubMed ID: 17176315
[TBL] [Abstract][Full Text] [Related]
16. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
Katz L; Strong DM; Tegtmeier G; Stramer S
Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
[TBL] [Abstract][Full Text] [Related]
17. Occult hepatitis B virus infection: implications in transfusion.
Allain JP
Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
[TBL] [Abstract][Full Text] [Related]
18. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
19. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
20. Naturally occurring MHR variants in Turkish patients infected with hepatitis B virus.
Sayiner AA; Ozcan A; Sengonul A
J Med Virol; 2008 Mar; 80(3):405-10. PubMed ID: 18205223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
